Bvf Inc Cytom X Therapeutics, Inc. Transaction History

Bvf Inc

$2.28 Billion
Q1 2025

A detailed history of Bvf Inc transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 5,228,461 shares of CTMX stock, worth $12.1 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,228,461

Previous 5,228,461 -0.0%

Holding current value

$12.1 Million

Previous $5.39 Million 37.86%

% of portfolio

0.15%

Previous 0.2%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.21 - $5.13 $1.65 Million - $7.01 Million	-1,367,340 Reduced 20.73%	5,228,461 $6.38 Million
Q3 2022 Nov 14, 2022	BUY	$1.23 - $1.97 $974,284 - $1.56 Million	792,101 Added 13.65%	6,595,801 $9.56 Million
Q4 2021 Feb 14, 2022	BUY	$3.87 - $7.39 $22.5 Million - $42.9 Million	5,803,700 New	5,803,700 $25.1 Million
Q2 2021 Aug 16, 2021	SELL	$6.33 - $9.91 $35.3 Million - $55.3 Million	-5,576,471 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$6.47 - $7.9 $13 Million - $15.9 Million	2,016,749 Added 56.65%	5,576,471 $36.5 Million
Q3 2020 Nov 13, 2020	BUY	$6.55 - $8.83 $2.91 Million - $3.92 Million	444,185 Added 14.26%	3,559,722 $23.7 Million
Q2 2020 Aug 14, 2020	SELL	$7.4 - $14.64 $5.97 Million - $11.8 Million	-806,436 Reduced 20.56%	3,115,537 $26 Million
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $11.4 Million - $27.1 Million	3,155,825 Added 411.91%	3,921,973 $30.1 Million
Q4 2019 Feb 14, 2020	SELL	$5.17 - $8.91 $5.74 Million - $9.9 Million	-1,111,000 Reduced 59.19%	766,148 $6.37 Million
Q3 2019 Nov 14, 2019	BUY	$7.38 - $12.25 $26,058 - $43,254	3,531 Added 0.19%	1,877,148 $13.9 Million
Q2 2019 Aug 14, 2019	BUY	$9.35 - $11.41 $6.32 Million - $7.71 Million	675,617 Added 56.4%	1,873,617 $21 Million
Q1 2019 May 15, 2019	BUY	$9.5 - $19.16 $11.4 Million - $23 Million	1,198,000 New	1,198,000 $12.9 Million
Q1 2018 May 07, 2018	SELL	$21.76 - $34.22 $24.5 Million - $38.5 Million	-1,124,483 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$19.0 - $23.09 $21 Million - $25.5 Million	-1,106,415 Reduced 49.6%	1,124,483 $23.7 Million
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $30.2 Million - $40.5 Million	2,230,898	2,230,898 $40.5 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

44.9M

Call Options Held

8.9K

Put Options Held

47.9K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $152M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Account